(Q41476029)

1 October 2017

1 reference

title

Principles and guidelines for surgeons--management of symptomatic breast cancer. European Society of Surgical Oncology (English)

1 reference

1 October 2017

M Blichert-Toft

1

1 reference

1 October 2017

M G Smola

series ordinal

2

1 reference

1 October 2017

L Cataliotti

series ordinal

3

1 reference

1 October 2017

N O'Higgins

series ordinal

4

1 reference

1 October 2017

publication date

1 April 1997

1 reference

European Journal of Surgical Oncology

1 October 2017

published in

1 reference

1 October 2017

volume

23

1 reference

1 October 2017

issue

2

1 reference

1 October 2017

page(s)

101-109

1 reference

Breast cancer 2000 BC to 2000 AD--time for a paradigm shift?

1 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2897%2980001-7

7 January 2021

Preoperative chemotherapy: where do we go from here?

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2897%2980001-7

7 January 2021

Changes in stage and treatment of breast cancer in Florence from 1985–1990

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2897%2980001-7

7 January 2021

Survival outcome of care by specialist surgeons in breast cancer: a study of 3786 patients in the west of Scotland

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2897%2980001-7

7 January 2021

Why do we need some large, simple randomized trials?

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2897%2980001-7

7 January 2021

Early breast cancer. A review

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2897%2980001-7

7 January 2021

Commission of the European Communities "Europe Against Cancer" Programme. European School of Oncology Advisory Report. Management of non-palpable and small lesions found in mass breast screening

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2897%2980001-7

7 January 2021

Genetic predisposition to breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2897%2980001-7

7 January 2021

Axillary dissection of level I and II lymph nodes is important in breast cancer classification. The Danish Breast Cancer Cooperative Group (DBCG)

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2897%2980001-7

7 January 2021

Prognostic significance of axillary nodal status in primary breast cancer in relation to the number of resected nodes. Stockholm Breast Cancer Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2897%2980001-7

7 January 2021

Audit of complete axillary dissection in early breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2897%2980001-7

7 January 2021

Extent, distribution, and mammographic/histological correlations of breast ductal carcinoma in situ

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2897%2980001-7

7 January 2021

The Nottingham prognostic index in primary breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2897%2980001-7

7 January 2021

The Nottingham Prognostic Index applied to 9,149 patients from the studies of the Danish Breast Cancer Cooperative Group (DBCG).

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2897%2980001-7

7 January 2021

Randomized consent designs for clinical trials: an update

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2897%2980001-7

7 January 2021

10.1016/S0748-7983(97)80001-7

Identifiers

DOI

1 reference

1 October 2017

1 reference